Kimberly-Clark Corporation (FRA:KMY)

Germany flag Germany · Delayed Price · Currency is EUR
89.42
+0.83 (0.94%)
Last updated: Nov 11, 2025, 1:19 PM CET
0.94%
Market Cap29.61B
Revenue (ttm)16.81B
Net Income (ttm)1.68B
Shares Outn/a
EPS (ttm)5.04
PE Ratio17.65
Forward PE13.38
Dividend4.50 (5.02%)
Ex-Dividend DateSep 5, 2025
Volume237
Average Volume179
Open89.51
Previous Close88.59
Day's Range89.42 - 89.51
52-Week Range86.97 - 136.66
Betan/a
RSI28.41
Earnings DateOct 30, 2025

About Kimberly-Clark

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. It operates through three segments: North America, International Personal Care, and International Family Care and Professional. The company North America segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers, and other related produc... [Read more]

Industry Paper Mills
Founded 1872
Employees 38,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol KMY
Full Company Profile

Financial Performance

In 2024, Kimberly-Clark's revenue was $20.06 billion, a decrease of -1.83% compared to the previous year's $20.43 billion. Earnings were $2.55 billion, an increase of 44.27%.

Financial numbers in USD Financial Statements

News

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kimberly-Clark Corporation (NASDAQ: KMB)

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and ...

6 days ago - GlobeNewsWire

Watch These Stocks Falling 10% Or More

Fiserv (FI) leads decliners with a 49% drop, driven by leadership turmoil, weak consumer spending, and a downgraded quant rating to 'Strong Sell.' Alexandria Real Estate (ARE) and Robert Half (RHI) su...

6 days ago - Seeking Alpha

Kenvue's $48.7 Billion Sale Puts Consumer Staples ETFs Back In Vogue

Consumer staples ETFs, usually the quiet corner of the market, are suddenly in the spotlight. The $48.7 billion acquisition of Kenvue Inc. (NYSE:KVUE) by Kimberly-Clark Corp (NASDAQ:KMB) has stirred r...

7 days ago - Benzinga

Analyst Robert Moskow Lowers Price Target for Kimberly-Clark (KMB) | KMB Stock News

Analyst Robert Moskow Lowers Price Target for Kimberly-Clark (KMB) | KMB Stock News

7 days ago - GuruFocus

KMB: Morgan Stanley Lowers Price Target on Kimberly-Clark | KMB Stock News

KMB: Morgan Stanley Lowers Price Target on Kimberly-Clark | KMB Stock News

7 days ago - GuruFocus

3 Dividend Stocks for November 2025

This month's trio includes two ADRs.

7 days ago - Morningstar

Kimberly-Clark (KMB) Shares Dip Following Acquisition Announcement

Kimberly-Clark (KMB) Shares Dip Following Acquisition Announcement

7 days ago - GuruFocus

Congressional Trading Report: Sen. Sheldon Whitehouse Sold Over $30K In Progressive Stock

November 3, 2025 records indicate that Senator Sheldon Whitehouse filed a sale of Progressive (NYSE: PGR), valued between $30,002 and $100,000. According to the November filing, the transaction occur...

7 days ago - Benzinga

This Kimberly-Clark Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Full story available on Benzinga.com

7 days ago - Benzinga

Tylenol to join Kleenex, Huggies and Listerine in $48.7 billion takeover deal between Kimberly-Clark and Kenvue

Shareholders of Kimberly-Clark will own about 54% of the combined company.

7 days ago - Fortune

Evercore ISI Downgrade: Kimberly-Clark (KMB) Target Price Lowered to $120 | KMB Stock News

Evercore ISI Downgrade: Kimberly-Clark (KMB) Target Price Lowered to $120 | KMB Stock News

7 days ago - GuruFocus

These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors?

Kimberly-Clark is creating a consumer health and wellness giant.

7 days ago - The Motley Fool

The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker

Mike Hsu aims to stoke the consumer company's growth by veering into Kenvue's higher-margin but risky health products.

7 days ago - WSJ

Palantir, Kimberly-Clark, Hims & Hers, Navitas And Cipher Mining: Why These 5 Stocks Are On Investors' Radars Today

On Monday, major U.S. indexes showed mixed performance — the Dow Jones Industrial Average slipped nearly 0.5% to 47,336.68, while the S&P 500 edged up 0.2% to 6,851.97. The Nasdaq closed 0.46% higher ...

7 days ago - Benzinga

Kimberly-Clark CEO Mike Hsu goes one-on-one with Jim Cramer

Kimberly-Clark Chairman and CEO Mike Hsu joins 'Mad Money' host Jim Cramer to talk the recent acquisition of Kenvue, quarterly results, consumer trends, and more.

7 days ago - CNBC Television

Tylenol concerns came out in the middle of our detailed due diligence process, says Kimberly-Clark CEO

Kimberly-Clark Chairman and CEO Mike Hsu joins 'Mad Money' host Jim Cramer to talk the recent acquisition of Kenvue, quarterly results, consumer trends, and more.

7 days ago - CNBC

Kimberly-Clark CEO Mike Hsu goes one-on-one with Jim Cramer

Kimberly-Clark Chairman and CEO Mike Hsu joins 'Mad Money' host Jim Cramer to talk the recent acquisition of Kenvue, quarterly results, consumer trends, and more.

7 days ago - CNBC

Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ...

7 days ago - Business Wire

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

Kimberly-Clark CEO Mike Hsu discussed his company's $48.7 billion acquisition of Kenvue in a Monday interview with CNBC's Jim Cramer.

7 days ago - CNBC

Kenvue's legal risks loom over planned acquisition by Kimberly-Clark

Kimberly-Clark said on Monday it plans to acquire Band-Aid maker Kenvue , even as the latter company faces thousands of lawsuits involving its painkiller Tylenol and talc-based baby powder, raising qu...

7 days ago - Reuters

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.

NEW YORK , Nov. 3, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Kenvue Inc. (NYSE: KVUE) and its board of directors concerning the proposed acquisition ...

7 days ago - PRNewsWire

Investor Outlook: Kimberly-Clark’s US$40B Kenvue deal marks new era of transformation

Kimberly-Clark’s US$40B Kenvue deal signals a strategic shift into consumer health and could reshape its position against Unilever and P&G.

7 days ago - BNN Bloomberg